These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 26622637

  • 1. Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Jin T, Chen XZ, Liu JJ.
    Oncol Lett; 2015 Aug; 10(2):1123-1130. PubMed ID: 26622637
    [Abstract] [Full Text] [Related]

  • 2. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
    Kong L, Zhang YW, Hu CS, Guo Y.
    Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
    [Abstract] [Full Text] [Related]

  • 3. Induction chemotherapy with nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
    Zheng J, Wang G, Yang GY, Wang D, Luo X, Chen C, Zhang Z, Li Q, Xu W, Li Z, Wang D.
    Jpn J Clin Oncol; 2010 May; 40(5):425-31. PubMed ID: 20085903
    [Abstract] [Full Text] [Related]

  • 4. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial.
    Cao SM, Yang Q, Guo L, Mai HQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Qiu F, Sun R, Chen QY, Huang PY, Luo DH, Hua YJ, Wu YS, Lv X, Wang L, Xia WX, Tang LQ, Ye YF, Chen MY, Guo X, Hong MH.
    Eur J Cancer; 2017 Apr; 75():14-23. PubMed ID: 28214653
    [Abstract] [Full Text] [Related]

  • 5. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.
    Kong L, Hu C, Niu X, Zhang Y, Guo Y, Tham IW, Lu JJ.
    Cancer; 2013 Dec 01; 119(23):4111-8. PubMed ID: 24037893
    [Abstract] [Full Text] [Related]

  • 6. The role of concurrent chemotherapy to intensity-modulated radiotherapy (IMRT) after neoadjuvant docetaxel and cisplatin treatment in locoregionally advanced nasopharyngeal carcinoma.
    Zhang L, Shan GP, Li P, Cheng PJ.
    Med Oncol; 2015 Mar 01; 32(3):41. PubMed ID: 25631634
    [Abstract] [Full Text] [Related]

  • 7. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
    Tang LQ, Chen DP, Guo L, Mo HY, Huang Y, Guo SS, Qi B, Tang QN, Wang P, Li XY, Li JB, Liu Q, Gao YH, Xie FY, Liu LT, Li Y, Liu SL, Xie HJ, Liang YJ, Sun XS, Yan JJ, Wu YS, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Lv X, Wang L, Xia WX, Zhao C, Cao KJ, Qian CN, Guo X, Hong MH, Nie ZQ, Chen QY, Mai HQ.
    Lancet Oncol; 2018 Apr 01; 19(4):461-473. PubMed ID: 29501366
    [Abstract] [Full Text] [Related]

  • 8. Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma.
    Liang Z, Wang S, Lin Z, Feng S, Cheng Z, Yang Y, Kuang Y, Fidelis C, Ullah S, Li F.
    Cancer Chemother Pharmacol; 2016 Mar 01; 77(3):643-51. PubMed ID: 26831498
    [Abstract] [Full Text] [Related]

  • 9. Neoadjuvant Chemotherapy with Fluorouracil plus Nedaplatin or Cisplatin for Locally Advanced Nasopharyngeal Carcinoma: a Retrospective Study.
    Liu T, Sun Q, Chen J, Li B, Qin W, Wang F, Ye Z, Hu F.
    J Cancer; 2018 Mar 01; 9(20):3676-3682. PubMed ID: 30405836
    [Abstract] [Full Text] [Related]

  • 10. Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma: Survival and toxicity.
    Xu J, He X, Cheng K, Guo W, Bian X, Jiang X, Zhang L, Huang S.
    Head Neck; 2014 Oct 01; 36(10):1474-80. PubMed ID: 23996842
    [Abstract] [Full Text] [Related]

  • 11. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
    Kong L, Zhang Y, Hu C, Guo Y, Lu JJ.
    Cancer; 2017 Jun 15; 123(12):2258-2267. PubMed ID: 28192641
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study.
    Qiu WZ, Huang PY, Shi JL, Xia HQ, Zhao C, Cao KJ.
    Chin J Cancer; 2016 Jan 06; 35():2. PubMed ID: 26739148
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma.
    Wang F, Jiang C, Ye Z, Sun Q, Liu T, Xu M, Wu P, Shi K, Long B, Rihito A, Masoto S, Fu Z.
    Oncotarget; 2017 Sep 26; 8(43):75544-75556. PubMed ID: 29088889
    [Abstract] [Full Text] [Related]

  • 14. Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.
    Yin L, Bian XH, Wang X, Chen M, Wu J, Xu JH, Qian PD, Guo WJ, Jiang XS, Zhu HF, Gu JJ, Wu JF, Zhang YW, He X.
    PLoS One; 2015 Sep 26; 10(9):e0137383. PubMed ID: 26367317
    [Abstract] [Full Text] [Related]

  • 15. Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trial.
    Tang C, Wu F, Wang R, Lu H, Li G, Liu M, Zhu H, Zhu J, Zhang Y, Hu K.
    Am J Cancer Res; 2016 Sep 26; 6(9):2064-2075. PubMed ID: 27725911
    [Abstract] [Full Text] [Related]

  • 16. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.
    Yang Q, Cao SM, Guo L, Hua YJ, Huang PY, Zhang XL, Lin M, You R, Zou X, Liu YP, Xie YL, Wang ZQ, Mai HQ, Chen QY, Tang LQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Li JB, Ling L, Guo X, Hong MH, Chen MY.
    Eur J Cancer; 2019 Sep 26; 119():87-96. PubMed ID: 31425966
    [Abstract] [Full Text] [Related]

  • 17. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
    Al-Amro A, Al-Rajhi N, Khafaga Y, Memon M, Al-Hebshi A, El-Enbabi A, El-Husseiny G, Radawi A, Belal A, Allam A, El-Sebaie M.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):508-13. PubMed ID: 15890594
    [Abstract] [Full Text] [Related]

  • 18. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
    Setakornnukul J, Thephamongkhol K.
    BMC Cancer; 2018 Mar 27; 18(1):329. PubMed ID: 29587665
    [Abstract] [Full Text] [Related]

  • 19. Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Zhang J, Chen S, Li G, Zhang W, Qin T, Yin P, Huang H, Jiang H.
    Cancer Chemother Pharmacol; 2017 Jun 27; 79(6):1087-1097. PubMed ID: 28429051
    [Abstract] [Full Text] [Related]

  • 20. Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinoma.
    Zhong YH, Dai J, Wang XY, Xie CH, Chen G, Zeng L, Zhou YF.
    Cancer Chemother Pharmacol; 2013 Jun 27; 71(6):1577-83. PubMed ID: 23549883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.